Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. (Record no. 19219557)

MARC details
000 -LEADER
fixed length control field 02468 a2200661 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515191535.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201001s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1527-7755
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1200/JCO.2009.23.2777
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Matulonis, Ursula A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100105
245 00 - TITLE STATEMENT
Title Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Date of publication, distribution, etc. Nov 2009
300 ## - PHYSICAL DESCRIPTION
Extent 5601-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fallopian Tube Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Maximum Tolerated Dose
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms, Glandular and Epithelial
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peritoneal Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinazolines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Vascular Endothelial Growth Factor
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Assessment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Berlin, Suzanne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ivy, Percy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tyburski, Karin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krasner, Carolyn
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zarwan, Corrine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Berkenblit, Anna
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Campos, Susana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Horowitz, Neil
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cannistra, Stephen A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, Hang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, Julie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roche, Maria
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hill, Margaret
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Whalen, Christin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sullivan, Laura
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tran, Chau
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Humphreys, Benjamin D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Penson, Richard T
773 0# - HOST ITEM ENTRY
Title Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Related parts vol. 27
-- no. 33
-- p. 5601-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1200/JCO.2009.23.2777">https://doi.org/10.1200/JCO.2009.23.2777</a>
Public note Available from publisher's website

No items available.